These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23031628)

  • 1. Individualisation or standardisation: trends in National Health Service prescription durations in England 1998-2009.
    Davies JE; Taylor DG
    Prim Health Care Res Dev; 2013 Apr; 14(2):164-74. PubMed ID: 23031628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prescription charges on repeat prescribing in primary care.
    Bradley F; Elvey R; Ashcroft DM; Noyce P
    J Clin Pharm Ther; 2007 Jun; 32(3):269-75. PubMed ID: 17489879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUSUM charts for monitoring clinical practice quality using primary care prescribing data: a case study of an initiative to encourage generic prescribing of proton pump inhibitors.
    Wood J; Lambert MF
    J Clin Pharm Ther; 2011 Dec; 36(6):680-6. PubMed ID: 21143614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.
    de Wet CJ; Reed LJ; Bearn J
    Addiction; 2005 Apr; 100(4):495-9. PubMed ID: 15784064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.
    Dietrich ES
    Int J Technol Assess Health Care; 2009 Jul; 25(3):262-71. PubMed ID: 19619344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A UK epidemic of testosterone prescribing, 2001-2010.
    Gan EH; Pattman S; H S Pearce S; Quinton R
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):564-70. PubMed ID: 23480258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the effect of a countywide protected learning time scheme on prescribing rates of ramipril: interrupted time series study.
    Siriwardena AN; Fairchild P; Gibson S; Sach T; Dewey M
    Fam Pract; 2007 Feb; 24(1):26-33. PubMed ID: 17052988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
    Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
    J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prescribing in primary care in Croatia, 2000-2012: prescribing volume, costs and regulatory measures.
    Vojvodić Z; Nelken-Bestvina D; Kurc-Bionda A; Stimac D
    Coll Antropol; 2014 Dec; 38 Suppl 2():67-72. PubMed ID: 25643530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in primary care prescribing: lessons to be learnt for GP commissioners.
    Houten R; Wailoo A; Jonsson P; McLeod C
    Prim Health Care Res Dev; 2014 Jan; 15(1):111-6. PubMed ID: 23714273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-psychotic drug prescribing trends in primary care in Scotland 1994-97.
    Stark C; Jones J; Agnew J; Hepburn T
    Health Bull (Edinb); 2000 Mar; 58(2):96-101. PubMed ID: 12813836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physician prescription behaviour using the example of general practitioners and their prescriptions of pharmaceuticals in Austria].
    Müller M; Meyer H; Stummer H
    Gesundheitswesen; 2011 Jul; 73(7):443-9. PubMed ID: 20865651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.
    Orzella L; Chini F; Giorgi Rossi P; Borgia P
    Health Policy; 2010 May; 95(2-3):236-44. PubMed ID: 20047773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the reduction of the prescription charge in Wales on the prescribing of non-sedating antihistamines in primary care.
    Dhippayom T; Walker R
    Health Policy; 2008 Sep; 87(3):309-15. PubMed ID: 18325622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.